Ancora Pharmaceuticals is categorized under Wholesale Pharmaceutical Products in Woburn, MA and active since 2002.
Ancora Pharmaceuticals was established in 2002, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 4242101 by the NAICS.
If you are seeking more information, feel free to contact John Pena Phd at the company’s single location by writing to 1 Gill St, Woburn, Massachusetts MA 01801 or by phoning (781) 281-0778. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Ancora Pharmaceuticals |
Contact Person: | John Pena Phd |
Address: | 1 Gill St, Woburn, Massachusetts 01801 |
Phone Number: | (781) 281-0778 |
Website Address: | ancorapharma.com |
Annual Revenue (USD): | $10.000.000 to $19.9999.999 |
Founded: | 2002 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Wholesale Pharmaceutical Products |
SIC Code: | 5122 |
NAICS Code: | 4242101 |
Share This Business: |
Ancora Pharmaceuticals was started in 2002 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 4242101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.
Feel free to contact John Pena Phd for inquiries that concern Ancora Pharmaceuticals by calling the company number (781) 281-0778, as your correspondence is most welcome. Additionally, the physical location of the single location of Ancora Pharmaceuticals can be found at the coordinates 42.5101,-71.14719 as well as the street address 1 Gill St in Woburn, Massachusetts 01801.
For its online presence, you may visit Ancora Pharmaceuticals’s website at ancorapharma.com and engage with its social media outlets through on Twitter and on Facebook.